<?xml version="1.0" encoding="UTF-8"?>
<p id="p0075">To counter chloroquine-resistant malaria, another antimalarial drug that is hydroxychloroquine (a chloroquine analog) was synthesized. Hydroxychloroquine is a 4-aminoquinoline with activities such as immunosuppression, anti-autophagy, and antimalarial (
 <xref rid="bib96" ref-type="bibr">McCreary and Pogue, 2020</xref>). Chloroquine and its derivative hydroxychloroquine have large total apparent amounts of delivery, as well as a one-month or longer half-lives of terminal removal that requires nearly a year to clear the body completely. Such long half-lives have made such medicines active anti-malaria prophylactic agents (
 <xref rid="bib96" ref-type="bibr">McCreary and Pogue, 2020</xref>).
</p>
